VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling.
Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling. Mol Cancer Ther. 2021 08; 20(8):1469-1480.
View in:
PubMed
subject areas
Antineoplastic Agents
Apoptosis
bcl-2-Associated X Protein
Biomarkers, Tumor
Biomimetics
Cell Proliferation
Cisplatin
Drug Synergism
Esophageal Neoplasms
Gene Expression Regulation, Neoplastic
Humans
Myeloid Cell Leukemia Sequence 1 Protein
Peptide Fragments
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-bcl-2
Tumor Cells, Cultured
authors with profiles
BRYAN BURT
MAHESHWARI RAMINENI
ROBERT RIPLEY